Alcon Inc. (LON:0A0D)

London flag London · Delayed Price · Currency is GBP · Price in CHF
64.48
+0.80 (1.26%)
Feb 20, 2026, 5:13 PM GMT
Market Cap30.19B -16.7%
Revenue (ttm)7.58B +4.3%
Net Income778.91M -9.8%
EPS1.56 -10.2%
Shares Outn/a
PE Ratio38.75
Forward PE25.00
Dividend0.25 (0.41%)
Ex-Dividend DateMay 13, 2025
Volume364,167
Average Volume463,146
Open64.50
Previous Close63.68
Day's Range63.96 - 65.44
52-Week Range57.70 - 86.98
Beta0.69
RSI62.73
Earnings DateFeb 25, 2026

About Alcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ... [Read more]

Sector Healthcare
Founded 1945
Employees 25,000
Stock Exchange London Stock Exchange
Ticker Symbol 0A0D
Full Company Profile

Financial Performance

In 2024, Alcon's revenue was $9.91 billion, an increase of 4.82% compared to the previous year's $9.46 billion. Earnings were $1.02 billion, an increase of 4.52%.

Financial numbers in USD Financial Statements